Federal regulators gave the green light to the first-ever vaccine to prevent the respiratory disease RSV on Wednesday, a major breakthrough that's been decades in the making. The Food and Drug Administration (FDA) approved Arexvy, a shot developed by pharmaceutical giant GlaxoSmithKline (GSK) to prevent lower respiratory tract disease caused by RSV in adults aged 60 and older. The development marks a significant turning point in the fight to protect vulnerable individuals against RSV, and other shots are close behind. A vaccine that was developed by Pfizer and aimed at the same demographic is expected to be approved by the end of the month. FDA is also considering Pfizer's ma
Read More Details
Finally We wish PressBee provided you with enough information of ( First-ever vaccine to prevent RSV in older adults wins FDA approval )
Also on site :